|
Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
This item is licensed under:Creative Commons Attribution 2.0 Generic
| Title: | microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway |
| Authors: | Mitamura, Takashi Browse this author | | Watari, Hidemichi Browse this author →KAKEN DB | | Wang, Lei Browse this author | | Kanno, Hiromi Browse this author | | Kitagawa, Makiko Browse this author | | Hassan, Mohamed Kamel Browse this author | | Kimura, Taichi Browse this author →KAKEN DB | | Tanino, Mishie Browse this author →KAKEN DB | | Nishihara, Hiroshi Browse this author →KAKEN DB | | Tanaka, Shinya Browse this author →KAKEN DB | | Sakuragi, Noriaki Browse this author →KAKEN DB |
| Keywords: | Endometrial cancer | | microRNA 31 | | LATS2 | | cyclin D1 | | Hippo pathway |
| Issue Date: | 29-Apr-2014 |
| Publisher: | Biomed Central Ltd |
| Journal Title: | Molecular Cancer |
| Volume: | 13 |
| Start Page: | 97 |
| Publisher DOI: | 10.1186/1476-4598-13-97 |
| PMID: | 24779718 |
| Abstract: | Background: We aimed to investigate whether MIR31 is an oncogene in human endometrial cancer and identify the target molecules associated with the malignant phenotype. Methods: We investigated the growth potentials of MIR31-overexpressing HEC-50B cells in vitro and in vivo. In order to identify the target molecule of MIR31, a luciferase reporter assay was performed, and the corresponding downstream signaling pathway was examined using immunohistochemistry of human endometrial cancer tissues. We also investigated the MIR31 expression in 34 patients according to the postoperative risk of recurrence. Results: The overexpression of MIR31 significantly promoted anchorage-independent growth in vitro and significantly increased the tumor forming potential in vivo. MIR31 significantly suppressed the luciferase activity of mRNA combined with the LATS2 3'-UTR and consequently promoted the translocation of YAP1, a key molecule in the Hippo pathway, into the nucleus. Meanwhile, the nuclear localization of YAP1 increased the transcription of CCND1. Furthermore, the expression levels of MIR31 were significantly increased (10.7-fold) in the patients (n = 27) with a high risk of recurrence compared to that observed in the low-risk patients (n = 7), and this higher expression correlated with a poor survival. Conclusions: MIR31 functions as an oncogene in endometrial cancer by repressing the Hippo pathway. MIR31 is a potential new molecular marker for predicting the risk of recurrence and prognosis of endometrial cancer. |
| Rights: | http://creativecommons.org/licenses/by/2.0/ |
| Type: | article |
| URI: | http://hdl.handle.net/2115/56760 |
| Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 渡利 英道
|
